This is a Validated Antibody Database (VAD) review about Rhesus mon.. CX3CR1, based on 16 published articles (read how Labome selects the articles), using CX3CR1 antibody in all methods. It is aimed to help Labome visitors find the most suited CX3CR1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CX3CR1 synonym: CX3C chemokine receptor 1
BioLegend
rat monoclonal (2A9-1) |
| BioLegend CX3CR1 antibody (BioLegend, 2A9-1) was used in flow cytometry on human samples (fig 1e). J Exp Med (2018) ncbi |
rat monoclonal (2A9-1) |
| BioLegend CX3CR1 antibody (Biolegend, 2A9-1) was used in flow cytometry on human samples (fig 2d). Ann Rheum Dis (2018) ncbi |
rat monoclonal (2A9-1) |
| In order to evaluate the effectiveness of adoptive natural killer cell therapy against the pulmonary metastasis of Ewing sarcoma, BioLegend CX3CR1 antibody (BioLegend, 2A9-1) was used in flow cytometry on human samples (fig s1). Oncoimmunology (2017) ncbi |
mouse monoclonal (K0124E1) |
| In order to map the lineage of human dendritic cells, BioLegend CX3CR1 antibody (BioLegend, KO124E1) was used in mass cytometry on human samples (fig 1j). Science (2017) ncbi |
rat monoclonal (2A9-1) |
| In order to map the lineage of human dendritic cells, BioLegend CX3CR1 antibody (BioLegend, 2A9-1) was used in flow cytometry on human samples (fig 2a). Science (2017) ncbi |
rat monoclonal (2A9-1) |
| In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend CX3CR1 antibody (Biolegend, 2A9-1) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi |
rat monoclonal (2A9-1) |
| In order to characterize activated T cells in joint tissue from patients with rheumatoid arthritis, BioLegend CX3CR1 antibody (biolegend, 2A9-1) was used in flow cytometry on human samples . Nature (2017) ncbi |
mouse monoclonal (K0124E1) |
| In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend CX3CR1 antibody (Biolegend, K0124E1) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi |
rat monoclonal (2A9-1) |
| In order to investigate the role of Eomes in the retention of liver natural killer cells, BioLegend CX3CR1 antibody (BioLegend, 2A9-1) was used in flow cytometry on human samples (fig 1e). J Immunol (2016) ncbi |
rat monoclonal (2A9-1) |
| BioLegend CX3CR1 antibody (Biolegend, 2A9-1) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2016) ncbi |
rat monoclonal (2A9-1) |
| BioLegend CX3CR1 antibody (Biolegend, 341610) was used in flow cytometry on human samples (fig 6). PLoS ONE (2015) ncbi |
rat monoclonal (2A9-1) |
| BioLegend CX3CR1 antibody (Biolegend, 2A9-1) was used in flow cytometry on human samples (fig 3). Clin Cancer Res (2015) ncbi |
rat monoclonal (2A9-1) |
| In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BioLegend CX3CR1 antibody (Biolegend, 2A9-1) was used in flow cytometry on human samples (fig 3). J Exp Med (2015) ncbi |
rat monoclonal (2A9-1) |
| BioLegend CX3CR1 antibody (Biolegend, 2A9-1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi |
rat monoclonal (2A9-1) |
| BioLegend CX3CR1 antibody (BioLegend, 2A9-1) was used in flow cytometry on human samples . Physiol Rep (2014) ncbi |
rat monoclonal (2A9-1) | BioLegend CX3CR1 antibody (BioLegend, 2A9-1) was used . J Exp Med (2014) ncbi | |
rat monoclonal (2A9-1) | In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, BioLegend CX3CR1 antibody (BioLegend, 2A9-1) was used . J Infect Dis (2014) ncbi |
Articles Reviewed
- Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments